Physician profile
Lawrence E Burns
NPI 1588606347
$4,178.77
in general payments reported to CMS, 2019-2025
18 companies · $448 in 2025
The $448 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,251 · 2021: $44.58 · 2022: $16.78 · 2023: $431 · 2024: $1,988 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461 · Travel and Lodging: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.35 |
| Travel and Lodging | $1,405.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,737.61 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $705.30 | 2019 | |
| Smith+Nephew, INC. | $361.88 | 2019-2024 | Grafix, Oasis |
| Globus Medical, INC. | $182.35 | 2025 | Senza |
| Nevro Corp. | $177.96 | 2024 | Senza |
| Stryker Corporation | $167.32 | 2023 | Salvation, Augment Injectable |
| Vaporox, INC. | $166.87 | 2023 | Vht-200 Wound Treatment System |
| Urgo Medical North America, LLC | $161.90 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organogenesis INC. | $147.48 | 2019-2021 | |
| Novo Nordisk INC | $117.83 | 2025 | Wegovy |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Crossroads Extremity Systems, LLC | $42.08 | 2019 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Abbvie INC. | $24.90 | 2024 | |
| Osiris Therapeutics INC. | $17.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.78 | 2022 | |
| Merck Sharp & Dohme LLC | $16.42 | 2019 | |
| Fusion Orthopedics USA, LLC | $9.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.